Montag A & Associates Inc Cassava Sciences Inc Transaction History
Montag A & Associates Inc
- $1.98 Billion
- Q1 2024
A detailed history of Montag A & Associates Inc transactions in Cassava Sciences Inc stock. As of the latest transaction made, Montag A & Associates Inc holds 1,500 shares of SAVA stock, worth $15,330. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,500
Previous 1,500
-0.0%
Holding current value
$15,330
Previous $33,000
9.09%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding SAVA
# of Institutions
172Shares Held
11.3MCall Options Held
1.61MPut Options Held
1.43M-
Black Rock Inc. New York, NY3.05MShares$31.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.36MShares$24.1 Million0.0% of portfolio
-
State Street Corp Boston, MA1.09MShares$11.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA902KShares$9.22 Million0.0% of portfolio
-
Gallacher Capital Management LLC Lone Tree, CO585KShares$5.98 Million6.03% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $410M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...